In VivoIn cancer therapeutics, one of the greatest challenges has been developing treatments that effectively target cancer cells while sparing healthy tissue. UK-based Avacta Therapeutics is pioneering a no
ScripPharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh
Scrip“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning
ScripJapan’s largest R&D hub for bioventures and pharma startups, Shonan Health Innovation Park (Shonan iPark), has been in active talks with Korean bioventures and government groups over the formation of